摘要
目的:观察三种不同药物治疗老年高血压患者血栓前状态的临床疗效。方法:将我院90例老年高血压患者随机分成三组,每组30例,A组服用中药痰瘀清方,B组在A组基础上口服西药苯磺酸氨氯地平,C组口服西药苯磺酸氨氯地平,治疗6周后,比较三组患者治疗前后收缩压、舒张压以及血浆PTS分子标志物水平变化情况。结果:A、B、C三组收缩压、舒张压均显著下降(P<0.05),A、B、C三组的血浆PTS分子标志物血管性血友病因子、D-二聚体和纤维蛋白原均有很好的改善(P<0.05);A组和B组老年高血压患者的血管性血友病因子、D-二聚体和纤维蛋白原与C组比较差异显著(P<0.05);B组与A组比较差异显著(P<0.05)。结论:中药痰瘀清方治疗老年高血压临床疗效显著,对血栓前状态具有很好的改善作用。
Objective:To observe efficacy of three different medicines on prethrombotic state in elderly hypertensive patients.Methods:90patients were divided into3groups.The group A was given the Tanyuqing prescription;the grorup B was given amlodipinebesylate more;the group C was given amlodipine besylate simply.Results:SBP and DBP in the group A,B,C were significantlydecreased(P<0.05);plasma PTS molecular markers von Willebrand factor,D-dimer and fibrinogen in the group A,B,C showed very goodimprovement(P<0.05);there were significant differences among the group A,B and C(P<0.05),and there was also a significant differencebetween the group B and A(P<0.05).Conclusion:The Tanyuqing prescription has obvious effects on hypertension in the elderly,and has agood effect on the prethrombotic state.
出处
《中医临床研究》
2017年第11期64-65,共2页
Clinical Journal Of Chinese Medicine
关键词
中药痰瘀清方
老年高血压
血栓前状态
临床疗效
The Tanyuqing prescription
Elderly hypertension
Prethrombotic state
Clinical efficacy
